Patient Buzz: Poorly Controlled Atopic Dermatitis | The Expert Weighs In
Atopic dermatitis (AD) that’s not fully under control was the subject of two Everyday Health articles: one on treatment “red flags” and another on insufficient care that’s accepted by patients as “good enough.” With so many factors contributing to AD flares, discerning when a treatment isn’t working or has stopped working can be a challenge for both patients and clinicians. Additiona …
Atopic dermatitis (AD) that’s not fully under control was the subject of two Everyday Health articles: one on treatment “red flags” and another on insufficient care that’s accepted by patients as “good enough.” With so many factors contributing to AD flares, discerning when a treatment isn’t working or has stopped working can be a challenge for both patients and clinicians. Additiona … Continue reading "Patient Buzz: Poorly Controlled Atopic Dermatitis | The Expert Weighs In"
Atopic dermatitis and prurigo nodularis are chronic, life-altering diseases with a common feature of debilitating pruritus that significantly impacts our patients’ qualities of life. For those with resistant and extensive disease, dermatologists now have nemolizumab in our armamentarium, the first FDA approved IL-31 inhibitor. We continue our series, Therapeutic Cheat Sheet, with a closer look a … 
Atopic dermatitis is a common, chronic, life-altering disease. With its visibility and debilitating pruritus, atopic dermatitis significantly impacts our patients’ quality of life. For those with resistant and extensive disease, we are happy to have numerous new systemic agents at our disposal, one being tralokinumab, an IL-13 antagonist. We continue our series, Therapeutic Cheat Sheet, with a c … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Adam Friedman (Professor and Chair of Dermatology who serves as Associate Residency Program Director, Director of Translational Research, and Director of the Supportive Oncodermatology Program in the GW Department of Dermatology) about the latest in Atopic Dermatitis (AD). Watch as he discu … 
Atopic dermatitis (AD) is a common skin condition characterized by pruritus and occurs as a result of factors related to impaired skin barrier and immune response, as well as environmental and infectious agents. Patients with poor control on topical therapy are looking for safe and effective systemic treatments. We continue our series, Therapeutic Cheat Sheet, with a closer look at dupilumab, whic …